Vertex Pharmaceuticals Stock Target Price and Analyst Consensus
| VRTX Stock | USD 459.81 3.46 0.75% |
The current analyst and expert consensus on Vertex Pharmaceuticals is Buy with 14 hold recommendations. The current projected Vertex Pharmaceuticals target price consensus is 500.30 with 34 analyst opinions. One of the most common ways Vertex Pharmaceuticals analysts use to provide buy-or-sell recommendation to the public are conference calls analysis and financial statements evaluations. Some experts can also talk to Vertex Pharmaceuticals vendors, executives, and/or customers. Vertex Pharmaceuticals recommendation module provides expert sentiment on the projected Vertex Pharmaceuticals target price to derive its highest and lowest estimates based on target price standard deviation of 1.9182.
Lowest Forecast 455.27 | Highest Forecast 555.33 | Target Price 500.3 |
It's important to approach Vertex Pharmaceuticals' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Vertex Pharmaceuticals Target Price Consensus
Vertex target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Vertex Pharmaceuticals' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 34 | Buy |
Most Vertex analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Vertex stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Vertex Pharmaceuticals, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationVertex Pharmaceuticals Target Price Projection
Vertex Pharmaceuticals' current and average target prices are 459.81 and 500.30, respectively. The current price of Vertex Pharmaceuticals is the price at which Vertex Pharmaceuticals is currently trading. On the other hand, Vertex Pharmaceuticals' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Vertex Pharmaceuticals Market Quote on 20th of July 2025
Target Price
Analyst Consensus On Vertex Pharmaceuticals Target Price
Vertex Pharmaceuticals Analyst Ratings
Vertex Pharmaceuticals' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Vertex Pharmaceuticals stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Vertex Pharmaceuticals' financials, market performance, and future outlook by experienced professionals. Vertex Pharmaceuticals' historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Vertex Pharmaceuticals price targets
Vertex Pharmaceuticals' stock target price is an estimate of its future price, usually made by analysts. Using Vertex Pharmaceuticals' target price to determine if it is a suitable investment can be done through the following steps:- Look at Vertex Pharmaceuticals' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Vertex Pharmaceuticals' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Vertex Pharmaceuticals Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Vertex Pharmaceuticals is a key component of Vertex Pharmaceuticals valuation and have some predictive power on the future returns of a Vertex Pharmaceuticals.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vertex Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Investor Favorites Invested over 30 shares | |
 | Social Domain Invested few shares | |
 | Macroaxis Index Invested few shares | |
 | Chemicals Invested over 40 shares | |
 | Driverless Cars Invested over 50 shares | |
 | Hedge Favorites Invested over 100 shares | |
 | Warren Buffett Holdings Invested few shares | |
 | Disruptive Technologies Invested few shares | |
 | Banking Invested over 40 shares | |
Additional Tools for Vertex Stock Analysis
When running Vertex Pharmaceuticals' price analysis, check to measure Vertex Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vertex Pharmaceuticals is operating at the current time. Most of Vertex Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Vertex Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vertex Pharmaceuticals' price. Additionally, you may evaluate how the addition of Vertex Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.